Do you need alcohol or drug treatment? If you are struggling with alcohol or drugs and feel an intense desire to do something different with your life, then medical detoxification or treatment may be an option that can turn your life around and set you on a path to freedom.
Everyday people get to a place in their lives where the alcohol or drugs quit working for them. The substances that they relied on to help them cope with life around them begins to stop working chemically, and these individuals experience a situation where they must take more and more of the same substance to produce the desired effect. The problem is the body was never equipped to handle larger amounts of substances into the body. The higher dosages create a negative biological response to the increased amount of substances taken. The body compensates to handle the new higher amount of substances by creating a tolerance which brings about a higher amount of substances needed to produce the desired effect. Hence the addictive cycle is in full motion.
Treatment for alcohol or drugs is the most logical choice for someone with a substance use disorder. However, to get help, one must ask for help for their disorder. Reaching out to an alcohol or drug treatment center is one option or contacting an addiction professional for help is another option. The main thing is once you recognize that a problem exists from substances in your life then the next step is to ask for help.
Here are some tips to help you find addiction treatment programs:
Tips for Finding Help
If you have medical insurance contact your insurance carrier to find out if you are covered for substance use disorder treatment. If you do not have insurance, then you need to determine if you can privately pay for alcohol or drug treatment. If that is not an option, then you will need to reach out to your State Health Service department or related division in your state. They often have websites designed to help you find a treatment provider. Many states offer indigent treatment.
Try and find a provider that is Licensed in the state and accredited by The Joint Commission or accredited by CARF.
Pick a treatment provider that offers screenings and assessments and focus on evidence-based treatment approaches. Experienced treatment centers often operate from evidence-based approaches.
Remember Treatment is designed to help you become free from alcohol and drugs. However, you must make the first approach and ask for help.
The 90-day treatment center is the gold standard for alcohol and drug treatment. Very simply the body needs the proper time to heal, and a 90-day treatment center offers an individual the time to heal from a substance use disorder. Addictions are very tricky in how they work on a person’s brain. The element of needing medical detoxification is important when dealing with a substance use disorder.
Choosing an alcohol and drug treatment that has a medical detoxification program attached to their 90-Day treatment center is ideal for two main reasons. One it allows a person time to become free from the harmful substances and two it allows a person to stay in the same program and not be moved around to an alternative place, keeping the treatment smooth and consistent.
Research has shown that those who fair the best post-discharge from an alcohol and drug treatment center are those that had 90-days of alcohol and drug treatment. When you attend a 90-Day treatment center, you protect yourself toward a future relapse.
One substance use disorder treatment center that comes highly recommended is in Stephenville, Texas. Summer Sky Treatment center is a program that has been around the treatment community since 1985 and has been getting amazing alcohol and drug treatment results with those that have attended their treatment centers. Summer Sky is passionate about helping men and women recover from alcohol and drugs. They offer a 90-Day treatment program and a traditional 30-day treatment option for those that cannot dedicate 90-days to treatment.
90-Day treatment centers are effective programs designed to deal with the physical, mental and emotional needs of those that have a substance use disorder. If you or a loved one is looking for high-quality alcohol or drug treatment 90-day or 30-day treatment center, reach out to Summer Sky, and they can help explain their 90-day treatment options. You can contact them at 1-888-858-8857.
NIH-funded multi-site clinical trial suggests that smokers may also benefit.
A new medication that targets part of the brain’s stress system may help reduce alcohol use in people with alcohol use disorder (AUD), according to a new study by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health.
“We’re committed to developing new medications to provide effective therapy to a broader spectrum of people with AUDs.”
—George F. Koob, Ph.D., Director, NIAAA
“Medications have become an important tool for treating alcohol use disorders, but current medications are not effective for all people with AUDs,” noted NIAAA Director George F. Koob, Ph.D. “We’re committed to developing new medications to provide effective therapy to a broader spectrum of people with AUDs.”
As reported online in the journal Neuropsychopharmacology, researchers led by Raye Litten, Ph.D., acting director of the NIAAA Division of Medications Development, conducted a randomized clinical trial of a new compound, called ABT-436, designed to block the effects of vasopressin, a neuropeptide produced in the hypothalamus of the brain.
“Vasopressin helps to regulate the pituitary adrenal axis and other brain circuits involved in emotion,” explained Dr. Litten. “As such, it plays a role in regulating stress, anxiety, and their interaction with AUD.”
Dr. Litten, first author Megan Ryan and their NIAAA colleagues worked with NIAAA’s multi-center Clinical Investigations Group, to recruit 144 alcohol-dependent adult men and women for the 12-week study. During a 28-day baseline period, female participants consumed at least 28 drinks per week, while male participants consumed at least 35 drinks per week. Participants were then randomized to receive either placebo tablets or ones containing the ABT-436 compound. Researchers monitored participants’ alcohol consumption, as well as their mood changes and smoking habits, as these are known to co-vary with alcohol consumption.
Researchers found that participants receiving ABT-436 experienced more days of alcohol abstinence than those receiving the placebo. In particular, participants who reported high levels of stress appeared to respond better to ABT-436, in that both the frequency of their drinking and the number of heavy drinking days they experienced decreased.
“Our findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress,” said first author Ryan, a clinical project manager in the NIAAA Division of Medications Development.
Smokers may be another population that could benefit from ABT-436. In addition to its effects on alcohol consumption, study participants receiving the new compound experienced a reduction in smoking. The researchers suspect that ABT-436 might be targeting the same areas in the brain that relate to withdrawal and stress, and, in the process, influencing both tobacco and alcohol use disorders. Additional research is needed to determine if that is the case.
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, is the primary U.S. agency for conducting and supporting research on the causes, consequences, prevention, and treatment of alcohol use disorder, and alcohol problems. NIAAA also disseminates research findings to general, professional, and academic audiences. Additional alcohol research information and publications are available at www.niaaa.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
September is here! It's the official month of recovery. Every year in September we celebrate addiction recovery all across the United States. This year will you please help us all celebrate that recovery is an option and millions do recovery from addictions.
Addiction Treatment is available to those who want and need treatment. Below is the Presidents Proclamation for Recovery Month.
Presidential Proclamation -- National Alcohol and Drug Addiction Recovery Month, 2015
NATIONAL ALCOHOL AND DRUG ADDICTION RECOVERY MONTH, 2015
- - - - - - -
BY THE PRESIDENT OF THE UNITED STATES OF AMERICA
Every day, resilient Americans with substance use disorders summon extraordinary courage and strength and commit to living healthy and productive lives through recovery. From big cities to small towns to Indian Country, substance use disorders affect the lives of millions of Americans. This month, we reaffirm our unwavering commitment to all those who are seeking or in need of treatment, and we recognize the key role families, friends, and health care providers play in supporting those on the path to a better tomorrow.
This year's theme is "Join the Voices for Recovery: Visible, Vocal, Valuable!" It encourages us all to do our part to eliminate negative public attitudes associated with substance use disorders and treatment. People in recovery are part of our communities -- they are our family and friends, colleagues and neighbors -- and by supporting them and raising awareness of the challenges they face, we can help eradicate prejudice and discrimination associated with substance use disorders, as well as with co-occurring mental disorders. Prevention and treatment work, and people recover -- and we must ensure all those seeking help feel empowered, encouraged, and confident in their ability to take control of their future. Americans looking for help for themselves or their loved ones can call 1-800-662-HELP or use the "Treatment Locator" tool atwww.SAMHSA.gov.
My Administration remains dedicated to pursuing evidence-based strategies to address substance use disorders as part of our National Drug Control Strategy. Seeking to widen pathways to recovery, our strategy supports the integration of substance use treatment into primary health care settings and the expansion of support services in places such as high schools, institutions of higher education, and throughout the criminal justice system. In the wake of public health crises related to non-medical use of prescription drugs and heroin in communities across our Nation, my Administration has pledged considerable resources to help Federal, State, and local authorities boost prevention efforts, improve public health and safety, and increase access to treatment in communities across the country. And the Affordable Care Act has extended substance use disorder and mental health benefits and Federal parity protections to millions of Americans.
Behavioral health is essential to overall health, and recovery is a process through which individuals are able to improve their wellness, live increasingly self-directed lives, and strive to fulfill their greatest potential. During National Alcohol and Drug Addiction Recovery Month, we reaffirm our belief that recovery and limitless opportunity are within reach of every single American battling substance use disorders, and we continue our work to achieve this reality.
NOW, THEREFORE, I, BARACK OBAMA, President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim September 2015 as National Alcohol and Drug Addiction Recovery Month. I call upon the people of the United States to observe this month with appropriate programs, ceremonies, and activities.
IN WITNESS WHEREOF, I have hereunto set my hand this thirty-first day of August, in the year of our Lord two thousand fifteen, and of the Independence of the United States of America the two hundred and fortieth.
Texas Based Drug Rehab Summer Sky is changing the face of addiction treatment. They are on course to launch some of the newest evidence based addiction practices as well as cutting edge recovery support systems in 2011. Traditional Drug Rehabs in the last five years have fallen behind the curve, when it comes to advancement of addiction treatment practices. Summer Sky who has been known to introduce new and innovative addiction practices is again making progress in the area of evidence based treatment practices. In 2009 Summer Sky begin the process of building a treatment team that is focused on quality of care and results. They introduced the first Texas 30 day model of treatment to incorporate Equine Therapy, Music Therapy, Art Therapy, Aquatic Therapy. This type of addiction expansion was unheard of for a 30 day treatment program. It was usually the practice of 90 day or long- term drug rehabs that offered this type of services. It did not take long for other Texas Drug Rehabs to begin the process of setting up programs that implemented this type of therapy practices. In 2010 Summer Sky once again pushed the status quo and implemented the first Recovery Team into and addiction treatment program in Texas.
This has allowed the clinical team to focus on solid clinical services and allow the recovery team to work with the clients on individual recovery, just like it is going to be when they get out of treatment. The lines have become clear for the clients on what the 12-steps are all about and how they fit into their life.
The Recovery Team and Clinical Team collaborate on many aspects of and individuals recovery and treatment. Also the facility implemented Massage therapy and Yoga to the programs. This is usually reserved for luxury facilities.
If you are looking for a rehab center that is making a difference in the Addiction Field Summer Sky is to place to go for great treatment.
Addictions, Centers and Counseling Services, Health, Partial hospitalization, Substance abuse, Substance dependence, Texas, Texas Drug and Alcohol Treatment, Texas Drug Rehab, Texas Drug Rehabs, Texas Drug Treatment, United States
The addiction treatment community has wrestled for years fighting addictions and pain. Programs have developed different approaches to treating those with chronic pain issues. It is a difficult and a delicate issue that concerns many in the medical and addiction treatment industry. How to properly detoxify a patient and treat the underline pain that the individual is suffering from can be very tricky. The patient will present for drug treatment with the desire to be removed from pain medications, however the fear from the patient of the pain that will present as soon as medications are removed from the body becomes a barrier for the individual seeking treatment. It is a double edge sword and if not properly done, can create unnecessary pain for the patient.
A powerful new painkiller, which was developed on the basis of the research conducted at Stony Brook University and with no apparent side effects or addictive qualities, may now be only a year or two from the consumer market.
"This offers a major paradigm shift in the control of pain," declares Dr. Simon Halegoua, Professor of Neurobiology & Behavior at Stony Brook who in the 1990s, teamed up with fellow Stony Brook professors Dr. Gail Mandel and Dr. Paul Brehm to identify a novel sodium ion channel involved in the transmission of pain. They predicted that a drug aimed at blocking this channel, PN1/Nav 1.7, would control pain. PN1 (Peripheral Neuron 1), is uniquely expressed in peripheral nerves such as those involved in pain transduction.
When a patient is given an opiate like morphine, pain signals are still transmitted from sensory nerves to the central nervous system. Morphine action throughout the brain reduces and alters pain perception, but it also impairs judgment and results in drug dependence," explains Halegoua, also director of the Center for Nervous System Disorders at Stony Brook University. "With drugs targeting the PN1/Nav1.7 sodium ion channel, the pain signals would not be transmitted, even by the sensory nerves. And since the central nervous system is taken out of the equation, there would be no side effects and no addictive qualities."
The potential for such drugs is enormous -- the reduction or elimination of pain for patients with cancer, arthritis, migraine headaches, muscle pain, pain from burns, and pain from other debilitating diseases.
He notes that drugs in both oral and topical ointment forms, based on the research he conducted in a basement laboratory at Stony Brook with Mandel, a molecular biologist, and Brehm, an electro physiologist, are currently in Phase II clinical trials in England and Canada.
The Research Foundation of the State University of New York is the holder of the various patents originating from the work of the Stony Brook researchers. Icagen Inc., now in partnership with Pfizer, holds the exclusive license to these patents and has announced their own drug has now entered Phase I clinical trials in the U.S.
The above story is reprinted (with editorial adaptations by Sober Sky) from materials provided by Stony Brook University.
addiction news, chronic pain, drug treatment news, Pain, Pain management, Patient, Pfizer, Stanford University, State University of New York, Stony Brook University, Substance dependence, Texas Drug Rehabs
FULTON, MISS. - When Neil Brown got high on bath salts, he took his skinning knife and slit his face and stomach repeatedly. Brown survived, but authorities say others haven't been so lucky after snorting, injecting or smoking powders with such innocuous-sounding names as Ivory Snow, Red Dove and Vanilla Sky.
Law enforcement agents and poison control centers say the bath salts, with their complex chemical names, are an emerging menace in several U.S. states where authorities talk of banning their sale. Some say their effects can be as powerful as those of methamphetamine.
From the Deep South to California, emergency calls are being reported over exposure to the stimulants the powders often contain: mephedrone and methylenedioxypyrovalerone, also known as MDPV.
Sold under such names as Ivory Wave, Bliss, White Lightning and Hurricane Charlie, the chemicals can cause hallucinations, paranoia, a rapid heart rate and suicidal thoughts, authorities say. In addition to bath salts, the chemicals can be found in plant foods that are sold legally at convenience stores and on the Internet. However, they aren't necessarily being used for the purposes on the label.
Mississippi lawmakers this week began considering a proposal to ban the sale of the powders, and a similar measure is being sought in Kentucky. In Louisiana, the bath salts were outlawed by an emergency order after the state's poison center received more than 125 calls in the last three months of 2010 involving exposure to the chemicals.
In Brown's case, he said he had tried every drug from heroin to crack and was so shaken by terrifying hallucinations that he wrote to one Mississippi paper urging people to stay away from the bath salts.
"I couldn't tell you why I did it," Brown said, pointing to his scars. "The psychological effects are still there."
While Brown survived, sheriff's authorities in one Mississippi county say they believe one woman overdosed on bath salts there. In southern Louisiana, the family of a 21-year-old man says he cut his throat and ended his life with a gunshot. Authorities are investigating whether a man charged with capital murder in the December death of a Tippah County, Miss., sheriff's deputy was under the influence of the bath salts.
The stimulants are not regulated by the Drug Enforcement Administration, but are facing federal scrutiny. Law officers say some of the substances are being shipped from Europe, but origins are still unclear.
Gary Boggs, an executive assistant at the DEA, said there is a lengthy process to restrict these types of designer chemicals, including reviewing the abuse data. But it's a process that can take years.
Mark Ryan, director of Louisiana's poison control center, said he thinks state bans on the chemicals can be effective. He said calls about the salts have dropped sharply since Louisiana banned their sale in January.
Ryan said cathinone, the parent substance of the drugs, comes from a plant grown in Africa and is regulated. He said that MDPV and mephedrone are made in a lab and that they are not regulated because they are not marketed for human consumption. The stimulants affect neurotransmitters in the brain, he said.
The drugs cause "intense cravings," he said. "They'll binge on it three or four days before they show up in an ER. Even though it's a horrible trip, they want to do it again and again."
Ryan said at least 25 states have received calls about exposure, including Nevada and California. He said Louisiana leads with the greatest number of cases at 165, or 48 percent of the U.S. total, followed by Florida with at least 38 calls to its poison center.
Rick Gellar, medical director for the California Poison Control System, said the first call about the substances came in Oct. 5, and a handful of calls have followed since. But he warned: "The only way this won't become a problem in California is if federal regulatory agencies get ahead of the curve. This is a brand-new thing."
In the Midwest, the Missouri Poison Center at Cardinal Glennon Children's Medical Center in St. Louis received at least 12 calls in the first two weeks of January about teenagers and young adults abusing such chemicals, said Julie Weber, the center's director. The center received eight calls about the powders all of last year.
Richard Sanders, a general practitioner working in Covington, La., said his son, Dickie, snorted some of the bath salts and endured three days of intermittent delirium. Dickie Sanders cut his throat but missed major arteries. As he continued to have visions, his physician father tried to calm him. But the elder Sanders said that as he slept, his son went into another room and shot himself.
"If you could see the contortions on his face. It just made him crazy," Sanders said. He added that the coroner's office confirmed that the chemicals were detected in his son's blood and urine.
Sanders warns that the bath salts are far more dangerous than some of their names imply.
"I think everybody is taking this extremely lightly. As much as we outlawed it in Louisiana, all these kids cross over to Mississippi and buy whatever they want," he said.
A small packet of the chemicals typically costs as little as $20.
In northern Mississippi's Itawamba County, Sheriff Chris Dickinson said his office has handled about 30 encounters with bath-salts users in the past two months alone. He said the problem grew last year in his rural area after a Mississippi law began restricting the sale of pseudoephedrine, a key ingredient in making methamphetamine.
Dickinson said most of the bath-salts users there have been meth addicts and can be dangerous when using them.
"We had a deputy injured a week ago. They were fighting with a guy who thought they were two devils. That's what makes this drug so dangerous," he said.
But Dickinson said the chemicals are legal, leaving him no choice but to slap users just with a charge of disorderly conduct, a misdemeanor.
Kentucky state lawmaker John Tilley said he's moving to block the drug's sale there, preparing a bill for consideration when his legislature convenes shortly. Angry that the powders can be bought legally, he said: "If my 12-year-old can go in a store and buy it, that concerns me."
ScienceDaily (Dec. 17, 2010) — A little-used medication can help treat alcoholism, an updated review of studies confirms. At any given time, about 5 percent of the population suffers from an addiction to alcohol, often with devastating consequences to work, family, friends and health. Twelve-step programs have been the mainstay for helping alcoholics to quit drinking, but a significant number of people who try these programs do not find them helpful or suffer relapses.
The Cochrane review finds that the medication naltrexone -- brand names are Depade and ReVia -- when combined with counseling or interventions like Alcoholics Anonymous, can help cut the risk of heavy drinking in patients who are dependent on alcohol.
Naltrexone works by blocking the pleasurable feelings, or "high," a person gets from drinking alcohol, thereby reducing motivation to drink. Naltrexone can be taken daily as a pill and is available as a long-acting injection.
The review was published by the Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
"Hundreds of drugs have been tried for relapse prevention [in alcoholism] and basically all others have failed," said Michael Soyka, M.D., senior author of the review. "From a clinical point of view, there are few pharmacologic options for the treatment of alcohol dependence, so it is important to study those options that look promising." Soyka and lead review author Suanne Roesner are associated with the psychiatric hospital at the University of Munich.
Alcohol dependence is different from alcohol abuse or misuse. The symptoms of alcohol dependence include craving for alcohol, an inability to control drinking, the presence of withdrawal symptoms if one tries to quit and tolerance -- the need to increase alcohol amounts to feel the same effect. People who only abuse alcohol and are not dependent on it have no trouble controlling their drinking, once they decide to do so.
Soyka and colleagues examined the results of 50 previously published high-quality studies on naltrexone and alcohol dependence. Overall, the studies enrolled nearly 7,800 patients diagnosed with alcohol dependence. Of these, about 4,200 patients took naltrexone or a similar drug called nalmefene. The rest of the patients took a placebo or had some other type of treatment. Treatment with naltrexone ranged from four weeks to a year, with most patients receiving about 12 weeks of treatment. Most patients also received counseling.
Researchers found that patients who received naltrexone were 17 percent less likely to return to heavy drinking than were patients who received a placebo treatment. "That would mean that naltrexone can be expected to prevent heavy drinking in one out of eight patients who would otherwise have returned to a heavy drinking pattern," Soyka said.
Naltrexone also increased the number of people who were able to stay abstinent by 4 percent.
While at first glance that might not seem like a miracle cure for alcoholism, Soyka said that the effectiveness of naltrexone is on par with medications used for other psychiatric conditions.
"Naltrexone is moderately effective in reducing alcohol intake. It's about as effective as antidepressants in depressive disorders," he said. "From a safety point of view, there are few safety concerns. Nausea is the most frequent side effect."
Carlton Erickson, Ph.D., director of the Addiction Science Research and Education Center at the University of Texas in Austin, says naltrexone can help a person with alcohol dependence move toward the goal of abstinence.
"Anytime you reduce the severity of drinking, the individual is more open to treatment for abstinence," he said. "It's almost like putting them through a series of steps if you can get them to cut down; once they start to cut down they are more likely to become abstinent with continued treatment and continued exposure to 12-step programs." Erickson is not associated with the review or any of its authors.
Despite its possible benefits in treating alcohol dependency, naltrexone is not widely used in the United States or elsewhere, Erickson said. Some addiction specialists fear that the widespread use of naltrexone or other medications will result in patients not receiving the counseling or psychological interventions they need.
There is also a lingering attitude that the treatment of alcohol dependency must rely solely on psychological or spiritual methods.
"People in 12-step programs typically don't believe in medications for the treatment of alcoholism," Erickson said. "Therefore they are unlikely to accept anyone into their 12-step meetings who is on a medication like naltrexone. Secondly, they would not want to accept it for themselves, unless a physician talked them into it as part of their treatment plan."
In addition, most large alcohol treatment centers, with the exception of Hazelden, do not advocate for the use of medications in the management of addiction, he said.
However, Erickson said that naltrexone is FDA-approved only as an adjunct to abstinence-based therapies, like Alcoholics Anonymous. "Naltrexone is not something you give to someone who says 'I want to stop drinking, give me a pill.' Naltrexone is only a helper to that process. The medication itself is not a magic bullet."
The review discloses that two authors received speaker/consultancy/advisory board honoraria from pharmaceutical companies.
In their study, published January 4, 2011, in the advanced online edition ofMolecular Therapy, the researchers say this novel strategy might be the first to offer cocaine addicts a fairly simple way to break and reverse their habit. The approach could also be useful in treating other addictions, such as to nicotine, heroin, and methamphetamine.
"Our very dramatic data shows that we can protect mice against the effects of cocaine, and we think this approach could be very promising in fighting addiction in humans," says the study's lead investigator, Ronald G. Crystal, chairman and professor of genetic medicine at Weill Cornell Medical College.
"The vaccine suppresses the stimulant effects of the drug," said Scripps Research Professor Kim Janda, a co-author of the paper and a pioneer in the field of developing vaccines against addictive drugs such as cocaine. "Unlike other types of treatment, a vaccine such as this one does not interfere with the neurological targets of the drug, but instead blocks cocaine from ever reaching the brain in the first place."
In the new study, the vaccine effect lasted for at least 13 weeks, the longest time point evaluated in such an approach. Since the vaccine likely will not require multiple expensive infusions, the researchers hope that it can move quickly into human trials.
Clinically, this sort of therapy could be given to people in treatment programs to aid in their recovery. And, like most other types of treatment, it will only be useful for those who want the help.
"This vaccine would be most applicable for addicts who are who are interested in getting off the drug," said Janda, the Eli R. Callaway Jr. Chair in Chemistry and a member of the Skaggs Institute for Chemical Biology at Scripps Research. "In essence we view such vaccines as 'immuno-helpers' for treating substance abuse, and, in the case at hand, it might prove to be extremely useful for crack addicts whose relapse rate is exceedingly high."
Cocaine, derived from the leaf of the Erythroxylaceae coca plant, is a highly potent drug that, as a salt, is either snorted or dissolved in water and injected directly into the bloodstream. The salt is also often neutralized to make an insoluble "free-base" form that is smoked.
Once ingested in the bloodstream, the drug crosses the blood - brain barrier and accumulates rapidly in the brain. "The brain levels rise very rapidly once cocaine is taken into the system," said Janda.
Addiction Articles, Addiction Consequences, Addiction Medicine, Addiction News, Addiction News, Addiction Treatment, Addiction Vaccines, Cocaine, cocaine addiction, Cocaine Dependence, Cocaine Rehab, Cocaine rehabs, Cocaine Treatment, cocaine vaccines, Common cold, Cornell University, Detox Centers, Detox Now, Erythroxylaceae, Kim Janda, National Institute on Drug Abuse, right step, Scott Kelley, Scott Kelley LCDC, Scripps Research Institute, sober, sober Austin, Sober California, Sober Florida, sober recovery, sober sky, sober Texas, Starlite Recovery Center, Summer Sky, Summer Sky rehab, Texas Drug Rehab, Texas Drug Rehabs, Texas drug rehabs Summer Sky, Weill Cornell Medical College of Cornell University